Skip to content

Association Between Fetal Inflammatory Response Syndrome and Bronchopulmonary Dysplasia in Premature Infants: A Case-Control Study

Association Between Fetal Inflammatory Response Syndrome and Bronchopulmonary Dysplasia in Premature Infants: A Case-Control Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052175
Enrollment
Unknown
Registered
2021-10-20
Start date
2021-10-20
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fetal inflammatory response syndrome(FIRS) and bronchopulmonary dysplasia (BPD)

Interventions

Observation group:None
control group:None

Sponsors

Shengjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Gestational age <32 weeks, weight <1500g, born in the obstetrics department of our hospital and admitted to the neonatology department for hospitalization after birth; 2. After admission, the children should complete the detection of IL-6 in the umbilical cord blood and (or) the pathological examination of the placenta by the mother.

Exclusion criteria

Exclusion criteria: 1. Children who were not born in this hospital and were transferred from other hospitals; 2. Preterm infants whose umbilical cord blood IL-6 test is not perfected or whose mother has not undergone placental pathological examination after admission; 3. Cases with incomplete and unreliable clinical case data and unclear medical history; 4. Corrected gestational age at discharge is less than 36 weeks; 5. Twin or multiple births; 6. Severe congenital heart disease, chromosomal disease, genetic metabolic disease and other serious malformations of the system; 7. Children who are discharged or die in the middle.

Design outcomes

Primary

MeasureTime frame
IL-6 of umbilical cord blood;

Countries

China

Contacts

Public ContactFu Jianhua

Shengjing Hospital of China Medical University

liying58522@163.com+86 18940251830

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026